Eric Benevich

Chief Commercial Officer at Neurocrine Biosciences · 14 reported transactions in 1 company · latest trade Sep 9, 2026

Their trades


Neurocrine BiosciencesNBIX	Sold $333K · 2,154 shares	Sep 9, 2026	S&P 500 +0.9%thru Oct 28

Sep 9, 2026 · NBIX

$333K

S&P 500 +0.9%thru Oct 28

Newest 10 of 14 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Commercial Officer at Neurocrine Biosciences · 14 reported transactions in 1 company · latest trade Sep 9, 2026


Neurocrine BiosciencesNBIX	Sold $333K · 2,154 shares	Sep 9, 2026	S&P 500 +0.9%thru Oct 28

Sep 9, 2026 · NBIX

$333K

S&P 500 +0.9%thru Oct 28

Newest 10 of 14 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.